In the UofA SSc cohort, Gal-9 levels were elevated in SSc-F patients (2303.91 pg/ml) when compared to SSc-NF patients (1654.10 pg/ml) (p=0.042) (Supplementary Table 4). The gene discussed is LGALS9; the disease is systemic sclerosis.